INCA33890 for neoplasm, residual

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Sep 2026: Trial registered, NCT07823322

The trials

NCT07823322: A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy

State
Under way
Phase
Phase 2
People
40 planned
Started
14 Dec 2026
Primary completion
14 May 2029
Arms
INCA33890
Results
None posted
  1. 16 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.